Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Ark-e-Kasni improves PCOS symptoms and may be a potential treatment.

Bicalutamide shows promise for treating female hair loss.

Newer contraceptives with less androgenic progestins may reduce female hair loss.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

Oral and topical finasteride are effective and safe for treating female hair loss.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Finasteride can cause enlarged breasts.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Spironolactone is generally safe and effective for treating hair loss in women, but may be less effective in severe cases.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Methotrexate may help stabilize frontal fibrosing alopecia.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

FLRG and follistatin have different roles in wound healing.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Nizoral improved menstrual cycles and reduced hair growth in patients with hyperandrogenism.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.